May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Stabilizing Indocyanin Green for Use as Quantitative Standards
Author Affiliations & Notes
  • A. Schwartz
    Ctr for Quantitative Cytometry, San Juan, Puerto Rico
  • L. Joline
    Research and Development,
    ThermoFisher, Inc., Portsmouth, New Hampshire
  • E. Snow
    ThermoFisher, Inc., Portsmouth, New Hampshire
  • S. Francke
    Custom Products,
    ThermoFisher, Inc., Portsmouth, New Hampshire
  • C. Marques
    Centro de Oftalmologia, IBILI, Coimbra, Portugal
  • R. Bernardes
    Instituto de Biofisica e Biomatematica, IBILI, AIBILI, Coimbra, Portugal
  • Footnotes
    Commercial Relationships  A. Schwartz, Pfizer, Inc., P; Pfizer, Inc., C; L. Joline, ThermoFisher, Inc., E; E. Snow, ThermoFisher, Inc., E; S. Francke, ThermoFisher, Inc., E; C. Marques, IBILI, F; R. Bernardes, IBILI, AIBLI, F.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 2116. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. Schwartz, L. Joline, E. Snow, S. Francke, C. Marques, R. Bernardes; Stabilizing Indocyanin Green for Use as Quantitative Standards. Invest. Ophthalmol. Vis. Sci. 2008;49(13):2116. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Indocyanin Green (ICG) is a dye used in ophthalmology to determine vessel development and leakage. However the stability of ICG solutions prepared for clinical use have only been approved for a period of 6 hours by the FDA. Obviously, six hours is not practical with respect of the use of ICG as a quantitative standard, therefore studies were conducted to determine the instability characteristics of ICG and how to achieve stability for long periods of time without changing the fluorescence characteristics of the dye.

Methods: : Initially, solutions of clinical grade ICG (ICG-PULSION - Medical System AG, Munich, Germany) were made and examined over time to determine their solution and fluorescence stability. Solution stability was determined by examination at 100 - 400X under a microscope. Fluorescence stability was determined by measuring the emission intensity of the ICG at 810 nm. A variety of different surfactants where tested to improve stability.

Results: : Solutions of ICG were made with de-ionized water and evaluated over time. The fluorescence intensity of these aqueous solutions was found to drop 80% over 100 hours. Solutions of ICG made in PBS pH 7.4 were found to drop 85% over 100 hours. Ionic surfactants, e.g., sodium dodecyl sulphate, had only minimal success in stabilization, however, non-ionic surfactants, e.g., Tween 20, were found to provide the necessary stability showing no significant (<5%) decrease in emission intensity over 4 months. Microscopic examination revealed that microscopic green crystals appeared suspended in the unstable fluorescent solutions, whereas the ICG in solutions containing 0.1% Tween 20 remained in solution.

Keywords: retina • retinal neovascularization • macular holes 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×